Oncology ASCO 2023 – Jennifer Elliott Some of the most impactful news out of ASCO 2023 dealt with new treatments for patients with few options in the status quo of cancer care.
News Skylark trials gene therapy for common form of child deafnes... Skylark Bio has dosed the first patient in a phase 1/2 trial of SKY-GJB2, a gene therapy for the most common form of genetic deafness in children.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
